What is Imilecleucel-T?

Category: Prescription Drugs

Most popular types: Tovaxin Tcelna

false

Imilecleucel-T is the generic in Tcelna (which was formerly called Tovaxin). It is a type of personalized T-cell immunotherapy being studied for the treatment of Secondary Progressive Multiple Sclerosis.

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe 0
Moderate 0
Mild 0
None 2

Commonly reported side effects and conditions associated with Imilecleucel-T

Side effect Patients

Why patients stopped taking Imilecleucel-T

Multiple reasons could be selected

Reason Patients
Course of treatment ended 3
Other 1
See all 3 patients who've stopped taking Imilecleucel-T

Duration

Stopped taking Imilecleucel-T

Duration Patients
6 months - 1 year 1
1 - 2 years 2
Adherence
Adherence Evaluations
Always 2
Usually 0
Sometimes 0
Never taken as prescribed 0
Burden
Burden Evaluations
Very hard to take 0
Somewhat hard to take 0
A little hard to take 1
Not at all hard to take 1
Cost per month
Cost per month Evaluations
$200+ 0
$100-199 0
$50-99 0
$25-49 0
< $25 2
Not specified 0
Last updated:

1 patient evaluation for Imilecleucel-T

Oct 14, 2008 (Started Jun 29, 2007)

  • Effectiveness
    Can't tell (for multiple sclerosis)
  • Side effects
    None
  • Adherence
    Always
  • Burden
    A little hard to take
Cost: < $25 monthly

Jun 20, 2008 (Started Jun 29, 2007)

  • Effectiveness
    Major (for multiple sclerosis)
  • Side effects
    None
  • Adherence
    Always
  • Burden
    Not at all hard to take
Dosage: As needed
Cost: < $25 monthly

  • 0 helpful marks
Last updated:
Showing 1 of 1 patient evaluation for Imilecleucel-T